Pacira BioSciences exceeded both EPS and revenue forecasts for Q1 2026. The stock price experienced a post-earnings decline but showed signs of recovery in pre-market trading.
Not the Sprint Jack Miller wanted, but there was still plenty of Aussie interest at Le Mans with Senna Agius on row four in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results